174 related articles for article (PubMed ID: 32424980)
1. Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
Bajaj NS; Kalra R; Gupta K; Aryal S; Rajapreyar I; Lloyd SG; McConathy J; Shah SJ; Prabhu SD
ESC Heart Fail; 2020 Aug; 7(4):1676-1687. PubMed ID: 32424980
[TBL] [Abstract][Full Text] [Related]
2. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
Cunningham JW; Vaduganathan M; Claggett BL; John JE; Desai AS; Lewis EF; Zile MR; Carson P; Jhund PS; Kober L; Pitt B; Shah SJ; Swedberg K; Anand IS; Yusuf S; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2020 Aug; 8(8):618-626. PubMed ID: 32387067
[TBL] [Abstract][Full Text] [Related]
3. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial.
Vaduganathan M; Claggett BL; Chatterjee NA; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Hegde SM; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):653-661. PubMed ID: 29501806
[TBL] [Abstract][Full Text] [Related]
4. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
[TBL] [Abstract][Full Text] [Related]
5. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
[TBL] [Abstract][Full Text] [Related]
6. Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
He X; Dong B; Liang W; Wu Y; Chen Y; Dong Y; He J; Liu C
Atherosclerosis; 2022 Mar; 344():1-6. PubMed ID: 35101783
[TBL] [Abstract][Full Text] [Related]
7. Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial).
Gupta K; Kalra R; Rajapreyar I; Joly JM; Pate M; Cribbs MG; Ather S; Prabhu SD; Bajaj NS
Am J Cardiol; 2020 May; 125(9):1347-1354. PubMed ID: 32151432
[TBL] [Abstract][Full Text] [Related]
8. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
[TBL] [Abstract][Full Text] [Related]
9. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT.
Grodin JL; Philips S; Mullens W; Nijst P; Martens P; Fang JC; Drazner MH; Tang WHW; Pandey A
Eur J Heart Fail; 2019 May; 21(5):634-642. PubMed ID: 30714658
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
[TBL] [Abstract][Full Text] [Related]
12. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
Silverman DN; Plante TB; Infeld M; Callas PW; Juraschek SP; Dougherty GB; Meyer M
JAMA Netw Open; 2019 Dec; 2(12):e1916598. PubMed ID: 31800067
[TBL] [Abstract][Full Text] [Related]
13. Mean corpuscular haemoglobin concentration and outcomes in heart failure with preserved ejection fraction.
Choy M; Zhen Z; Dong B; Chen C; Dong Y; Liu C; Liang W; Xue R
ESC Heart Fail; 2023 Apr; 10(2):1214-1221. PubMed ID: 36695165
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
[TBL] [Abstract][Full Text] [Related]
15. Abnormal electrocardiogram and poor prognosis in heart failure with preserved ejection fraction.
He T; Liu C; Liang W
Postgrad Med J; 2023 Oct; 99(1177):1154-1159. PubMed ID: 37427981
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
Beldhuis IE; Myhre PL; Bristow M; Claggett B; Damman K; Fang JC; Fleg JL; McKinlay S; Lewis EF; O'Meara E; Pitt B; Shah SJ; Vardeny O; Voors AA; Pfeffer MA; Solomon SD; Desai AS
J Am Coll Cardiol; 2021 Mar; 77(9):1211-1221. PubMed ID: 33663739
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT.
Barkoudah E; Claggett BL; Lewis EF; O'Meara E; Clausell N; Diaz R; Fleg JL; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
J Card Fail; 2022 Sep; 28(9):1390-1397. PubMed ID: 35636727
[TBL] [Abstract][Full Text] [Related]
18. Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT.
Ferreira JP; Liu J; Claggett BL; Vardeny O; Pitt B; Pfeffer MA; Solomon SD; Zannad F
Eur J Heart Fail; 2022 Feb; 24(2):378-384. PubMed ID: 34755426
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
20. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
Peters AE; Pandey A; Ayers C; Wegermann K; McGarrah RW; Grodin JL; Abdelmalek MF; Bekfani T; Blumer V; Diehl AM; Moylan CA; Fudim M
ESC Heart Fail; 2021 Apr; 8(2):842-848. PubMed ID: 33586354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
